Overall rank by patents
#3,348
Across all tracked assignees
USPTO PatentsView assignee record - 111 granted patents across 100 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Imperial holds 111 US patents across 100 technology areas, rank #3,348 of 50,000 tracked assignees.
Imperial Innovations Limited has been granted 111 US utility patents between 2015 and 2025, placing Imperial Innovations Limited at rank #3,348 across all assignees tracked by PlainPatent. This portfolio spans 100 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.4 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Imperial Innovations Limited is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Imperial sits between Emitec Gesellschaft Fuer Emissionstechnologie Mbh (111 patents, rank #3,344) and MUSC Foundation For Research Development (111 patents, rank #3,352) - the closest US assignees by grant volume. The composite Innovation Score of 51.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 15 grants, compared with 96 in the 2015–2019 window, a -84% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Imperial Innovations Limited's 15.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Imperial Innovations Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EMITEC Gesellschaft fuer Emissionstechnologie mbH
111 patents
Global Life Sciences Solutions USA LLC
111 patents
Goldman Sachs & Co. LLC
111 patents
HongQiSheng Precision Electronics (QinHuangDao) Co., Ltd.
111 patents
Janssen Sciences Ireland UC
111 patents
Kulicke and Soffa Industries, Inc.
111 patents
MACNEIL IP LLC
111 patents
MUSC Foundation for Research Development
111 patents
IMPERIAL INNOVATIONS LIMITED
111 patents
What this shows Imperial holds 111 patents at rank #3,348, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,348 in granted patent volume.
Other assignees with the most granted patents in Imperial's primary technology class.
Imperial's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 9 | 8.1% |
| 2016 | 27 | 24.3% |
| 2017 | 18 | 16.2% |
| 2018 | 24 | 21.6% |
| 2019 | 18 | 16.2% |
| 2020 | 6 | 5.4% |
| 2021 | 3 | 2.7% |
| 2022 | 5 | 4.5% |
| 2025 | 1 | 0.9% |
Top 15 of 100 technology areas
Overall rank by patents
#3,348
Across all tracked assignees
51.8 out of 100
How to use this portfolio
Imperial's 111 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.